ArticleFrontiers in pharmacology2020

Anti-IL-6 Versus Anti-IL-6R Blocking Antibodies to Treat Acute Ebola Infection in BALB/c Mice: Potential Implications for Treating Cytokine Release Syndrome.

Reid Rubsamen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.